Patients with LTBI who are also on dialysis are at increased risk for progression to TB disease and thus may receive increased benefit from TPT.75 However, they are also at increased risk of treatment-related adverse events.76,77 As such, close monitoring is suggested in this patient group. Dose adjustment based on renal function is not required for INH, rifampin or rifapentine.
Switch To: Français